Keith A. Goldan, Chief Financial Officer at Syndax Pharmaceuticals Inc (SNDX), sold 1,177 shares at $18.99 ($22K) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Seasonal sale ($22k) by Chief Financial Officer — this insider has traded SNDX in June in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| SNDX | SELL | 2025-07-18 | $12K | — | Filing → |
| SNDX | SELL | 2025-02-12 | $117K | — | Filing → |
| SNDX | BUY | 2024-06-17 | $25K | — | Filing → |